Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pain Management

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1775034

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1775034

Non-opioid Pain Treatment

PUBLISHED:
PAGES: 480 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Non-opioid Pain Treatment Market to Reach US$66.0 Billion by 2030

The global market for Non-opioid Pain Treatment estimated at US$44.0 Billion in the year 2024, is expected to reach US$66.0 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Non-Steroidal Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$29.6 Billion by the end of the analysis period. Growth in the Acetaminophen Drugs segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.0 Billion While China is Forecast to Grow at 11.1% CAGR

The Non-opioid Pain Treatment market in the U.S. is estimated at US$12.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$13.9 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Non-Opioid Pain Treatment Market - Key Trends & Drivers Summarized

Why Is the Global Healthcare Industry Moving Away from Opioid-Based Pain Management?

The global transition toward non-opioid pain treatment represents one of the most significant shifts in modern pain management, catalyzed by growing concerns over opioid addiction, dependence, and associated healthcare burdens. In response to decades of rising opioid misuse-particularly in North America-clinicians, regulators, and pharmaceutical innovators are prioritizing safer, non-addictive alternatives for both acute and chronic pain. The devastating consequences of opioid overprescription have led to regulatory crackdowns, medical guideline revisions, and a major cultural rethinking of how pain should be treated. This has created a fertile environment for non-opioid treatments, which include a wide range of pharmaceuticals (such as NSAIDs, antidepressants, and anticonvulsants), targeted biologics, nerve-blocking agents, and device-based therapies like TENS (Transcutaneous Electrical Nerve Stimulation) and spinal cord stimulators. Many of these treatments can effectively manage pain without altering mood, cognitive function, or risking dependence, making them attractive across patient demographics-from elderly patients with arthritis to younger populations recovering from sports injuries or surgeries. In palliative and post-operative care, multimodal approaches are now becoming the norm, wherein non-opioid solutions are integrated with physical therapy, psychological support, and lifestyle adjustments. As awareness grows around the risks of opioids-even when taken under medical supervision-patients themselves are increasingly seeking out and requesting non-opioid alternatives, placing additional pressure on healthcare systems to evolve. This global paradigm shift is redefining pain treatment not just as a clinical challenge but as a multidisciplinary, personalized, and public health-driven priority.

How Are Innovations in Pharmacology and Medical Devices Expanding the Pain Treatment Toolbox?

Recent innovations in pharmacology and medical technology are vastly expanding the range and efficacy of non-opioid pain treatments, offering hope for millions of patients previously dependent on narcotics for relief. On the pharmaceutical front, companies are developing novel compounds that target specific pain pathways without affecting the brain’s reward system-thereby reducing the potential for misuse. For instance, selective nerve growth factor (NGF) inhibitors are showing promise for chronic conditions like osteoarthritis, while COX-2 inhibitors and next-generation NSAIDs are delivering improved pain relief with reduced gastrointestinal risks. Beyond oral drugs, localized delivery systems such as topical gels, transdermal patches, and injectable biologics offer site-specific relief with minimal systemic exposure. On the medical device side, wearable technologies that modulate nerve signals-like TENS units and neuromodulation implants-are emerging as effective solutions for conditions such as neuropathy, fibromyalgia, and post-surgical pain. These non-invasive or minimally invasive devices are particularly appealing in outpatient settings where patients require long-term symptom management without pharmacologic intervention. Virtual reality (VR)-based therapies, which use distraction and cognitive reframing techniques, are also being explored for pain reduction in clinical trials. Meanwhile, AI-powered platforms are helping clinicians tailor pain treatment regimens to individual patients by analyzing genetics, behavior, and lifestyle data. The convergence of biotechnology, digital therapeutics, and precision medicine is making non-opioid pain treatment not only viable but in many cases, preferable. These innovations are transforming how pain is understood and addressed-shifting the focus from suppression to modulation and long-term management.

Are Public Health Policies and Payer Strategies Accelerating the Shift to Non-Opioid Options?

The rising adoption of non-opioid pain treatments is being significantly driven by public health policies, insurance payer strategies, and institutional prescribing guidelines aimed at curbing opioid dependency. In the wake of national opioid crises, governments across the globe-especially in the U.S., Canada, and Australia-are implementing stringent prescription monitoring programs and providing grants for the development and dissemination of non-opioid pain solutions. Regulatory agencies like the FDA have fast-tracked approval for several non-opioid pain relief drugs and devices, recognizing the urgent need for alternatives. Insurance companies are revising reimbursement frameworks to support broader coverage of non-opioid therapies, including non-pharmacological interventions such as physical therapy, acupuncture, chiropractic care, and cognitive behavioral therapy (CBT). Some healthcare systems are also introducing financial incentives for hospitals and clinics that adopt opioid-sparing protocols. Moreover, professional associations in orthopedics, dentistry, anesthesiology, and palliative care have issued updated guidelines recommending non-opioid options as first-line treatments for specific conditions or post-operative scenarios. Educational campaigns are simultaneously targeting both physicians and the public, emphasizing the long-term dangers of opioids and presenting safer, evidence-based alternatives. Hospitals and academic medical centers are launching dedicated pain management programs that integrate multiple non-opioid modalities to treat pain holistically. These policy-level efforts are not only reshaping medical practice standards but are also reducing stigma around non-drug and non-opioid approaches, fostering a new culture of sustainable, patient-centered pain management.

What Factors Are Driving the Growth of the Non-Opioid Pain Treatment Market Globally?

The growth in the non-opioid pain treatment market is driven by several interlinked factors spanning technology, healthcare delivery, patient behavior, and epidemiological trends. Technologically, the development of safer, more targeted therapies-including biologics, nerve blockers, and digital therapeutics-is expanding the clinical viability of non-opioid pain management across a wider array of conditions. The increasing prevalence of chronic pain-stemming from aging populations, sedentary lifestyles, surgical procedures, and conditions like arthritis, cancer, and diabetes-is creating sustained global demand for effective and tolerable pain solutions. Clinically, the integration of multidisciplinary care teams and personalized medicine approaches is reinforcing the need for diverse, non-addictive treatment modalities. From a systems perspective, healthcare providers are prioritizing opioid-sparing strategies to reduce legal liabilities, improve patient satisfaction, and meet institutional performance metrics. Insurance coverage is gradually becoming more inclusive of non-opioid therapies, enabling broader patient access and reducing out-of-pocket costs. On the consumer side, growing health literacy and social awareness around opioid-related harm are pushing patients to actively seek alternative treatments and advocate for safer care pathways. Additionally, the COVID-19 pandemic exposed the vulnerability of opioid-dependent systems, further validating the importance of decentralized, device-based, or non-pharmacologic interventions that can be managed at home. Pharmaceutical companies and medtech firms are responding with robust R&D pipelines and strategic partnerships aimed at expanding market penetration globally. Together, these technological, clinical, economic, and cultural shifts are driving a durable and accelerating wave of growth in the non-opioid pain treatment market.

SCOPE OF STUDY:

The report analyzes the Non-opioid Pain Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Drug Class (Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs, Other Drug Classes); Pain (Chronic Pain, Post-operative Pain, Cancer Pain, Other Pains); Route of Administration (Oral Route of Administration, Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Almatica Pharma LLC
  • Amgen Inc.
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Fresenius Kabi AG
  • GlaxoSmithKline plc (GSK)
  • Haleon Group
  • Heron Therapeutics
  • Hyloris Pharmaceuticals
  • Johnson & Johnson Consumer Inc.
  • LNK International, Inc.
  • Novartis AG
  • Pacira Pharmaceuticals, Inc.
  • Perrigo Company plc
  • Pfizer Inc.
  • Pierrel S.p.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vertex Pharmaceuticals Incorporated

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32376

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Non-opioid Pain Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Opioid Addiction Crisis Throws the Spotlight on Safer, Non-Addictive Pain Management Alternatives
    • Heightened Regulatory Scrutiny and Prescribing Restrictions Strengthen the Business Case for Non-Opioid Therapies
    • Shift Toward Multimodal Pain Management Approaches Propels Growth in Non-Opioid Treatment Options
    • Surging Demand for Chronic Pain Relief Among Aging Populations Expands the Addressable Market Opportunity
    • Innovations in Targeted Drug Delivery and Non-Systemic Therapies Drive Adoption Across Diverse Indications
    • Advancements in Neuromodulation and Non-Invasive Devices Accelerate Demand for Non-Pharmacologic Interventions
    • Rise in Post-Surgical and Musculoskeletal Conditions Spurs Uptake of Non-Opioid Pain Solutions in Acute Care Settings
    • Integration with Digital Therapeutics and AI-Based Treatment Planning Enhances Patient Outcomes and Market Viability
    • Growing Preference for Personalized and Precision Medicine Supports Development of Condition-Specific Non-Opioid Regimens
    • Workplace Wellness Programs and Employer Health Initiatives Generate Demand for Safer Pain Relief Options
    • Expanding Use in Pediatrics and Geriatrics Drives the Need for Non-Opioid Treatments with Favorable Safety Profiles
    • Broader Consumer Awareness of Opioid Risks Fuels Patient-Led Demand for Safer, Sustainable Pain Treatments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Non-opioid Pain Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Non-opioid Pain Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Non-opioid Pain Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Acetaminophen Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Acetaminophen Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Acetaminophen Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Local Anesthetics Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Local Anesthetics Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Local Anesthetics Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Topical Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Topical Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Topical Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Injectable Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Injectable Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Injectable Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Route of Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Oral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Oral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Oral Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Post-operative Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Post-operative Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Post-operative Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Cancer Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Cancer Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Cancer Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other Pains by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other Pains by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Other Pains by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: USA 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • JAPAN
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • CHINA
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 86: China Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: China 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • EUROPE
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Non-opioid Pain Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Non-opioid Pain Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Europe 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Europe 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • FRANCE
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 113: France Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 119: France Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: France 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: France 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • GERMANY
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Germany 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Germany 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Italy 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Italy 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 149: UK Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 155: UK Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: UK 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: UK 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Spain 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Spain 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Spain 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Russia 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Russia 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Russia 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Non-opioid Pain Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Australia 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Australia 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Australia 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • INDIA
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 224: India Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 227: India Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: India 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 230: India Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: India 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: India 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: South Korea 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: South Korea 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: South Korea 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Non-opioid Pain Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Non-opioid Pain Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Latin America 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Latin America 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Argentina 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Argentina 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Argentina 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Brazil 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Brazil 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Brazil 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Mexico 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Mexico 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Mexico 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Non-opioid Pain Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Non-opioid Pain Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Middle East 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Middle East 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Iran 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Iran 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Iran 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Israel 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Israel 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Israel 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: UAE 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: UAE 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: UAE 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030
  • AFRICA
    • Non-opioid Pain Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Non-opioid Pain Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Non-opioid Pain Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen Drugs, Local Anesthetics Drugs and Other Drug Classes for the Years 2015, 2025 & 2030
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Non-opioid Pain Treatment by Route Of Administration - Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 403: Africa 15-Year Perspective for Non-opioid Pain Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Topical Route of Administration, Injectable Route of Administration, Other Route of Administrations and Oral Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Non-opioid Pain Treatment by Distribution Channel - Retail Pharmacies, Hospital Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 406: Africa 15-Year Perspective for Non-opioid Pain Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospital Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Non-opioid Pain Treatment by Pain - Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 409: Africa 15-Year Perspective for Non-opioid Pain Treatment by Pain - Percentage Breakdown of Value Sales for Chronic Pain, Post-operative Pain, Cancer Pain and Other Pains for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!